EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children

Yu Ding iD, Qianwen Zhang iD, Shiyang Gao iD, Juan Li iD, Guoying Chang iD, Yirou Wang iD, Libo Wang iD, Xin Li iD, Yao Chen iD, Ru-En Yao iD, Tingting Yu iD, Niu Li iD und 2 weitere

Pediatric Diabetes · 2025

DOI: 10.1155/pedi/8155443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Diabetes, 2025. Verfasst von Yu Ding und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, Chi…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this study, we analysed the clinical and genetic characteristics and follow‐up data of patients with maturity‐onset diabetes of the young (MODY).

Methods

From January 2015 to December 2022, patients with persistent hyperglycaemia suspected of having monogenic diabetes or diabetes syndrome were recruited, and next‐generation sequencing (NGS) was performed at the Shanghai Children’s Medical Center. Patients’ clinical and laboratory findings were recorded preceding follow‐ups. Candidate variants were verified using Sanger sequencing. Variant pathogenicity was evaluated according to the American College of Medical Genetics and Genomics (ACMG) guidelines.

Results

Genetic testing was performed in 175 children. MODY‐related pathogenic or likely pathogenic gene variants were identified in 30 patients from different families. Of these, 11 were diagnosed with GCK ‐MODY (36.7%), six with INS ‐MODY (20%), five with HNF1A ‐MODY (16.7%), five with ABCC8 ‐MODY (16.7%), two with HNF1B ‐MODY (6.7%) and one with HNF4A ‐MODY (3.3%). There was one shift variant and seven splice‐site variants, and the rest were missense variants. We discovered six novel variants. Of the 30 patients, 63.3% had a family history of diabetes, 13.3% had diabetic ketoacidosis (DKA), and 16.7% had positive diabetes‐associated autoantibodies. The diabetes phenotype of patients with the INS variant was similar to that of patients with type 1 diabetes. All patients, including those having positive autoantibodies, required long‐term insulin therapy during follow‐ups. Four patients with the ABCC8 variant were unable to switch to oral sulfonylurea therapy and continued insulin therapy.

Conclusion

Genetic testing is helpful for the precise diagnosis and treatment of patients with MODY, including those with DKA history and positive diabetes autoantibody. GCK ‐MODY is the most common type of MODY, and patients with INS variant account for a relatively large proportion of MODY cases in our cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansChildMaleFemaleAdolescentChild, PreschoolGenetic TestingHepatocyte Nuclear Factor 1-alphaGerminal Center KinasesFollow-Up StudiesMutation

Stichwörter der Autor:innen

MODYchildhoodnext-generation sequencingrare subtypes

Substanzen

Hepatocyte Nuclear Factor 1-alphaGerminal Center Kinases

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
  • Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
  • Department of Reproductive Genetics, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • Department of Pediatrics, The First Affiliated Hospital of Henan University of Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.

ORCID-Profile: Yu Ding, Qianwen Zhang, Shiyang Gao, Juan Li, Guoying Chang, Yirou Wang, Libo Wang, Xin Li, Yao Chen, Ru-En Yao, Tingting Yu, Niu Li, Dan Lou, Xiumin Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Ding, Y., Zhang, Q., Gao, S., Li, J., Chang, G., Wang, Y., Wang, L., Li, X., Chen, Y., Yao, R. E., Yu, T., Li, N., Lou, D., & Wang, X. (2025). Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children. Pediatric Diabetes. https://doi.org/10.1155/pedi/8155443

Vancouver

Ding Y, Zhang Q, Gao S, Li J, Chang G, Wang Y, et al. Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children. Pediatric Diabetes. 2025. doi:10.1155/pedi/8155443

BibTeX
@article{Ding2025,
  author = {Ding, Yu and Zhang, Qianwen and Gao, Shiyang and Li, Juan and Chang, Guoying and Wang, Yirou and Wang, Libo and Li, Xin and Chen, Yao and Yao, Ru-En and Yu, Tingting and Li, Niu and Lou, Dan and Wang, Xiumin},
  title = {Focusing on Rare Variants Related to Maturity‐Onset Diabetes of the Young in Children},
  journal = {Pediatric Diabetes},
  year = {2025},
  doi = {10.1155/pedi/8155443}
}
Kostenlos starten →